HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International Sales Reps’ COVID-19 Claims Bring Problems Home For US Supplement Direct Seller

Executive Summary

"While several of the posts emanated from overseas, a number of the active posts include US area codes and contact email addresses and appear to have originated in North America,” industry self-regulation group says of Gano Excel.

You may also be interested in...



Direct Seller Representatives' COVID-19 Claims Sent To FTC By Industry Self-Regulation Group

RBC Life Sciences may face regulatory scrutiny after ignoring BBB National Programs' questions about sales representatives’ COVID-19 claims and for potential income and its unauthorized use of accreditation logos.

Direct Sales Industry Guidance Responds To ‘Increase In Questionable Earnings Claims’

Direct Selling Self-Regulatory Council and Direct Selling Association guidance aims to curb multi-level marketers’ misleading earnings claims, a practice increasing among health and wellness direct sellers during the COVID-19 pandemic.

FTC Warns Health And Wellness Direct Sellers Preying On Pandemic-Stressed Consumers

FTC warned 10 US direct sellers about false claims for health and wellness products that prey on consumer fears over COVID-19. The agency says it will continue to monitor the market for unfounded health claims as well as direct sellers' statements about distributors' potential earnings.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel